25 results
10-K
2024 FY
IXHL
Incannex Healthcare Limited
30 Sep 24
Annual report
7:30am
harm our business and/or reputation, and subject us to significant fines and liability.
We are exposed to fluctuations in exchange rates which may … liable for injury caused to individuals exposed to or taking our drug candidates; and
our reputation may suffer.
In addition, adverse side effects
8-K
EX-10.2
IXHL
Incannex Healthcare Limited
10 Sep 24
Entry into a Material Definitive Agreement
7:30am
and in the amounts customarily insured against by entities of established reputation having similar properties similarly situated and in such amounts
S-1/A
IXHL
Incannex Healthcare Limited
17 Jul 24
IPO registration (amended)
8:47am
may result in:
decreased demand for our drug candidates;
injury to our reputation;
withdrawal of clinical trial participants;
costs of related … such third-party intellectual property rights. Any of these events, even if we were ultimately to prevail, could result in injury to our reputation
S-1
IXHL
Incannex Healthcare Limited
3 Jul 24
IPO registration
6:29am
or eventual outcome, liability claims may result in:
decreased demand for our drug candidates;
injury to our reputation;
withdrawal of clinical trial … result in injury to our reputation or require us to divert substantial financial and management resources that we would otherwise be able to devote to our
8-K
EX-14.1
IXHL
Incannex Healthcare Limited
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
Exhibit 14.1
Incannex Healthcare Inc.
Code of Conduct
Introduction
The reputation and integrity of Incannex Healthcare Inc. and its subsidiaries
8-K
EX-10.2
py4uyzro
29 Nov 23
Entry into a Material Definitive Agreement
4:36pm
6-K
EX-99.1
e40vzhk de
1 Sep 23
Report of Foreign Private Issuer
12:00am
6-K
EX-99.1
zf9sm
27 Jul 23
Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement
8:47pm
6-K
EX-99.1
d888jszlsuw6ggrz 82r
10 Jul 23
Incannex Announces Intention to Redomicile to United States, List all Shares on Nasdaq
8:43am
6-K
EX-99.1
dgniyzda h7
30 May 23
Report of Foreign Private Issuer
8:02am
20-F
wz8 uxt9558l
28 Oct 22
Annual report (foreign)
6:31am
6-K
EX-99.1
85unacn57n
19 Sep 22
Report of Foreign Private Issuer
9:38pm
6-K
EX-99.1
77zuj64d
12 May 22
Report of Foreign Private Issuer
9:25am
20FR12B/A
f4azqo5pu061a4pu 9yg
24 Feb 22
Initial registration of securities (foreign private issuers) (amended)
3:42pm
20FR12B/A
fzcmdw5qzb13q 6ui
22 Feb 22
Initial registration of securities (foreign private issuers) (amended)
6:10am
20FR12B
ugj5oia ya
24 Jan 22
Initial registration of securities (foreign private issuers)
8:18pm
20FR12B
EX-4.2
93kcm10lkvbr0k1b3r
24 Jan 22
Initial registration of securities (foreign private issuers)
8:18pm
F-1/A
065xcccklfme2bzc7xvj
7 Dec 21
Registration statement (foreign) (amended)
5:21pm